2023 Q4 Form 10-Q Financial Statement

#000000695523000085 Filed on December 22, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q4
Revenue $142.0M $160.6M $139.4M
YoY Change 1.86% 5.78% 6.48%
Cost Of Revenue $67.72M $81.70M $71.48M
YoY Change -5.25% 4.62% 0.28%
Gross Profit $74.25M $78.90M $67.91M
YoY Change 9.34% 7.01% 13.89%
Gross Profit Margin 52.3% 49.13% 48.72%
Selling, General & Admin $42.22M $50.90M $53.25M
YoY Change -20.72% -6.83% 9.84%
% of Gross Profit 56.86% 64.51% 78.41%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.426M $3.800M $4.193M
YoY Change -18.29% 133.42% -18.98%
% of Gross Profit 4.61% 4.82% 6.17%
Operating Expenses $42.22M $52.00M $53.25M
YoY Change -20.72% -7.58% 9.84%
Operating Profit $28.66M $26.90M $12.31M
YoY Change 132.85% 53.96% 92.12%
Interest Expense -$3.697M -$3.200M -$2.815M
YoY Change 31.33% 86.15% 192.92%
% of Operating Profit -12.9% -11.9% -22.87%
Other Income/Expense, Net -$991.0K -$700.0K -$702.0K
YoY Change 41.17% -372.37% 46.25%
Pretax Income $23.97M $28.30M $8.792M
YoY Change 172.68% 142.63% 77.04%
Income Tax $5.669M $5.200M $2.383M
% Of Pretax Income 23.65% 18.37% 27.1%
Net Earnings $17.74M $22.20M $7.453M
YoY Change 138.0% 98.78% 167.32%
Net Earnings / Revenue 12.49% 13.82% 5.35%
Basic Earnings Per Share $0.33 $0.13
Diluted Earnings Per Share $0.32 $0.41 $0.13
COMMON SHARES
Basic Shares Outstanding 54.34M shares 56.87M shares
Diluted Shares Outstanding 55.01M shares 57.32M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $148.0M $154.4M $129.2M
YoY Change 14.48% 27.92% 2.14%
Cash & Equivalents $148.0M $154.4M $129.2M
Short-Term Investments
Other Short-Term Assets $30.53M $24.80M $33.66M
YoY Change -9.3% -22.22% -7.07%
Inventory $80.08M $74.77M $90.66M
Prepaid Expenses
Receivables $94.93M $97.65M $97.71M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $360.0M $355.6M $352.7M
YoY Change 2.07% 3.68% -2.33%
LONG-TERM ASSETS
Property, Plant & Equipment $37.96M $38.97M $41.78M
YoY Change -9.14% -5.81% -12.46%
Goodwill $266.5M $266.5M $261.7M
YoY Change 1.86% 3.31% -4.26%
Intangibles $37.73M $37.34M $41.03M
YoY Change -8.05% -10.04% -20.17%
Long-Term Investments
YoY Change
Other Assets $63.38M $64.16M $77.25M
YoY Change -17.96% -13.36% -2.15%
Total Long-Term Assets $405.6M $407.0M $421.7M
YoY Change -3.82% -1.91% -6.57%
TOTAL ASSETS
Total Short-Term Assets $360.0M $355.6M $352.7M
Total Long-Term Assets $405.6M $407.0M $421.7M
Total Assets $765.6M $762.6M $774.4M
YoY Change -1.14% 0.62% -4.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $45.51M $50.48M $74.67M
YoY Change -39.06% -30.39% 17.64%
Accrued Expenses $21.78M $43.00M $23.44M
YoY Change -7.11% 95.72% 32.35%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $4.375M $3.750M $1.875M
YoY Change 133.33% -6.25%
Total Short-Term Liabilities $127.0M $148.1M $154.1M
YoY Change -17.62% -2.84% 17.1%
LONG-TERM LIABILITIES
Long-Term Debt $240.1M $210.3M $200.4M
YoY Change 19.85% 5.17% 14.49%
Other Long-Term Liabilities $60.58M $61.61M $65.78M
YoY Change -7.91% -21.18% -11.48%
Total Long-Term Liabilities $300.7M $271.9M $266.1M
YoY Change 12.99% -2.23% 6.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $127.0M $148.1M $154.1M
Total Long-Term Liabilities $300.7M $271.9M $266.1M
Total Liabilities $443.9M $436.0M $440.1M
YoY Change 0.87% -0.49% 9.29%
SHAREHOLDERS EQUITY
Retained Earnings $1.029B $1.011B $974.2M
YoY Change 5.61% 4.59% 1.89%
Common Stock $240.3M $16.75M $231.9M
YoY Change 3.61% 0.44% 3.32%
Preferred Stock
YoY Change
Treasury Stock (at cost) $826.6M $800.5M $742.8M
YoY Change 11.28% 7.76% 11.25%
Treasury Stock Shares 26.56M shares
Shareholders Equity $321.7M $326.6M $334.3M
YoY Change
Total Liabilities & Shareholders Equity $765.6M $762.6M $774.4M
YoY Change -1.14% 0.62% -4.69%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q4
OPERATING ACTIVITIES
Net Income $17.74M $22.20M $7.453M
YoY Change 138.0% 98.78% 167.32%
Depreciation, Depletion And Amortization $3.426M $3.800M $4.193M
YoY Change -18.29% 133.42% -18.98%
Cash From Operating Activities -$6.675M $50.60M $17.53M
YoY Change -138.07% 13.61% -470.99%
INVESTING ACTIVITIES
Capital Expenditures $1.567M $1.000M -$3.028M
YoY Change -151.75% -169.11% -8.05%
Acquisitions $0.00
YoY Change
Other Investing Activities -$1.027M $20.10M $493.0K
YoY Change -308.32% 111566.67% 270.68%
Cash From Investing Activities -$2.594M $19.10M -$2.535M
YoY Change 2.33% -1436.6% -19.78%
FINANCING ACTIVITIES
Cash Dividend Paid $2.178M $2.274M
YoY Change -4.22% -5.6%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $2.317M -57.40M -$5.688M
YoY Change -140.73% 42.3% 53.03%
NET CHANGE
Cash From Operating Activities -$6.675M 50.60M $17.53M
Cash From Investing Activities -$2.594M 19.10M -$2.535M
Cash From Financing Activities $2.317M -57.40M -$5.688M
Net Change In Cash -$6.459M 12.30M $8.544M
YoY Change -175.6% 343.4% -161.83%
FREE CASH FLOW
Cash From Operating Activities -$6.675M $50.60M $17.53M
Capital Expenditures $1.567M $1.000M -$3.028M
Free Cash Flow -$8.242M $49.60M $20.56M
YoY Change -140.09% 7.86% -1534.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
29727622 shares
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
28772715 shares
CY2022Q4 epac Ascend Transformation Program Expenses In Cogs
ASCENDTransformationProgramExpensesInCOGS
0 usd
CY2023Q3 us-gaap Derivative Instruments In Hedges At Fair Value Net
DerivativeInstrumentsInHedgesAtFairValueNet
-1200000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
45505000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
50483000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21775000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33194000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4375000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3750000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
826622000 usd
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
800506000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1028871000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1011112000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-120840000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-121210000 usd
CY2023Q4 epac Stock Held In Trust
StockHeldInTrust
3576000 usd
CY2023Q3 epac Stock Held In Trust
StockHeldInTrust
3484000 usd
CY2023Q4 epac Deferred Compensation Liability
DeferredCompensationLiability
3576000 usd
CY2023Q3 epac Deferred Compensation Liability
DeferredCompensationLiability
3484000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
321676000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
326620000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
765567000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
762597000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
17738000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
7453000 usd
CY2023Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
567000 usd
CY2022Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1044000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
18305000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
6409000 usd
CY2023Q4 epac Impairmentdivestiturecharges
Impairmentdivestiturecharges
147000 usd
CY2022Q4 epac Impairmentdivestiturecharges
Impairmentdivestiturecharges
0 usd
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3426000 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4193000 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
2717000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
2155000 usd
CY2023Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-24000 usd
CY2022Q4 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-33000 usd
CY2023Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
146000 usd
CY2022Q4 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
460000 usd
CY2023Q4 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1527000 usd
CY2022Q4 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-11000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2517000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9844000 usd
CY2023Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4590000 usd
CY2022Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5684000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-4984000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
2130000 usd
CY2023Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
9089000 usd
CY2022Q4 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
8377000 usd
CY2023Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
1051000 usd
CY2022Q4 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
5104000 usd
CY2023Q4 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-11154000 usd
CY2022Q4 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1529000 usd
CY2023Q4 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-3912000 usd
CY2022Q4 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
73000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3917000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
17814000 usd
CY2023Q4 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-2758000 usd
CY2022Q4 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-281000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6675000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17533000 usd
CY2023Q4 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1567000 usd
CY2022Q4 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2535000 usd
CY2023Q4 epac Proceeds From Issuance Of Term Loan
ProceedsFromIssuanceOfTermLoan
0 usd
CY2022Q4 epac Proceeds From Issuance Of Term Loan
ProceedsFromIssuanceOfTermLoan
200000000 usd
CY2023Q4 epac Payment For Redemption Of Revolver
PaymentForRedemptionOfRevolver
0 usd
CY2022Q4 epac Payment For Redemption Of Revolver
PaymentForRedemptionOfRevolver
-200000000 usd
CY2023Q4 us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
0 usd
CY2022Q4 us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
-4000000 usd
CY2023Q4 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 usd
CY2022Q4 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2417000 usd
CY2023Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
26116000 usd
CY2022Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2023Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2081000 usd
CY2022Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
969000 usd
CY2023Q4 epac Stock Option Exercises Other
StockOptionExercisesOther
2317000 usd
CY2022Q4 epac Stock Option Exercises Other
StockOptionExercisesOther
972000 usd
CY2023Q4 us-gaap Payments Of Dividends
PaymentsOfDividends
2178000 usd
CY2022Q4 us-gaap Payments Of Dividends
PaymentsOfDividends
2274000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2317000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-5688000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2317000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5688000 usd
CY2023Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
493000 usd
CY2022Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-766000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6459000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
8544000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
154415000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
120699000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
147956000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
129243000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
102230000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
102268000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
19299000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
18394000 usd
CY2023Q4 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
-689000 usd
CY2023Q3 us-gaap Aoci Loss Cash Flow Hedge Cumulative Gain Loss After Tax
AociLossCashFlowHedgeCumulativeGainLossAfterTax
548000 usd
CY2023Q4 epac Land Buildings And Improvements
LandBuildingsAndImprovements
14174000 usd
CY2023Q3 epac Land Buildings And Improvements
LandBuildingsAndImprovements
14070000 usd
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
137809000 usd
CY2023Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
136566000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
151983000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
150636000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
114020000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
111668000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
37963000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38968000 usd
CY2023Q4 us-gaap Revenues
Revenues
141970000 usd
CY2022Q4 us-gaap Revenues
Revenues
139382000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
94925000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
97649000 usd
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
6468000 usd
CY2023Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
3989000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3469000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
2927000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
16500000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
16800000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
13200000 usd
CY2023Q4 us-gaap Concentration Risk Customer
ConcentrationRiskCustomer
11.7
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3500000 usd
CY2022Q1 epac Incremental Operating Profit Minimum
IncrementalOperatingProfitMinimum
40000000 usd
CY2022Q1 epac Incremental Operating Profit Maximum
IncrementalOperatingProfitMaximum
50000000 usd
CY2023Q4 epac Incremental Operating Profit Minimum
IncrementalOperatingProfitMinimum
50000000 usd
CY2023Q4 epac Incremental Operating Profit Maximum
IncrementalOperatingProfitMaximum
60000000 usd
CY2022Q1 epac Anticipated Invested Expense Minimum
AnticipatedInvestedExpenseMinimum
60000000 usd
CY2022Q1 epac Anticipated Invested Expense Maximum
AnticipatedInvestedExpenseMaximum
65000000 usd
CY2023Q4 epac Ascend Transformation Program Costs
ASCENDTransformationProgramCosts
3600000 usd
CY2022Q4 epac Ascend Transformation Program Costs
ASCENDTransformationProgramCosts
10400000 usd
CY2023Q4 epac Ascend Transformation Program Expenses In Sga
ASCENDTransformationProgramExpensesInSGA
1100000 usd
CY2022Q4 epac Ascend Transformation Program Expenses In Sga
ASCENDTransformationProgramExpensesInSGA
9400000 usd
CY2023Q4 epac Ascend Transformation Program Expenses In Cogs
ASCENDTransformationProgramExpensesInCOGS
100000 usd
CY2023Q4 epac Anticipated Additional Investment Expense Minimum
AnticipatedAdditionalInvestmentExpenseMinimum
10000000 usd
CY2022Q4 epac Anticipated Additional Investment Expense Maximum
AnticipatedAdditionalInvestmentExpenseMaximum
15000000 usd
CY2023Q4 epac Anticipated Additional Ascend Transformation Program Restructuring Charges Minimum
AnticipatedAdditionalASCENDTransformationProgramRestructuringChargesMinimum
3000000 usd
CY2022Q4 epac Anticipated Additional Ascend Transformation Program Restructuring Charges Maximum
AnticipatedAdditionalASCENDTransformationProgramRestructuringChargesMaximum
5000000 usd
CY2022Q2 epac Anticipated Ascend Transformation Program Restructuring Charges Minimum
AnticipatedASCENDTransformationProgramRestructuringChargesMinimum
6000000 usd
CY2022Q2 epac Anticipated Ascend Transformation Program Restructuring Charges Maximum
AnticipatedASCENDTransformationProgramRestructuringChargesMaximum
10000000 usd
CY2023Q4 epac Restructuring Charges Including Recorded In Cost Of Goods Sold
RestructuringChargesIncludingRecordedInCostOfGoodsSold
2400000 usd
CY2022Q4 epac Restructuring Charges Including Recorded In Cost Of Goods Sold
RestructuringChargesIncludingRecordedInCostOfGoodsSold
1000000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
266494000 usd
CY2023Q4 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
44000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
266538000 usd
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
145348000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
107622000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
37726000 usd
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
144140000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
106802000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
37338000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
2500000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2900000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
1900000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
1800000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1700000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
1500000 usd
CY2023Q4 epac Finite Lived Intangible Assets Amortization Expense Year Six
FiniteLivedIntangibleAssetsAmortizationExpenseYearSix
1000000 usd
CY2023Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
856000 usd
CY2022Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1140000 usd
CY2023Q4 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
45000 usd
CY2022Q4 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
234000 usd
CY2023Q4 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
164000 usd
CY2022Q4 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
256000 usd
CY2023Q4 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
2000 usd
CY2022Q4 us-gaap Standard And Extended Product Warranty Accrual Foreign Currency Translation Gain Loss
StandardAndExtendedProductWarrantyAccrualForeignCurrencyTranslationGainLoss
18000 usd
CY2023Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
739000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
1136000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
245125000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
214750000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
4375000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3750000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
622000 usd
CY2023Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
663000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
240128000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
210337000 usd
CY2022Q3 epac Senior Credit Facilty
SeniorCreditFacilty
600000000 usd
CY2023Q4 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
100000 usd
CY2023Q3 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
100000 usd
CY2023Q4 us-gaap Interest Rate Cash Flow Hedge Derivative At Fair Value Net
InterestRateCashFlowHedgeDerivativeAtFairValueNet
500000 usd
CY2023Q3 us-gaap Interest Rate Cash Flow Hedge Derivative At Fair Value Net
InterestRateCashFlowHedgeDerivativeAtFairValueNet
700000 usd
CY2023Q4 us-gaap Derivative Instruments In Hedges At Fair Value Net
DerivativeInstrumentsInHedgesAtFairValueNet
-1200000 usd
CY2023Q4 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
100000 usd
CY2023Q3 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
100000 usd
CY2023Q4 epac Gain Loss On Foreign Currency Fair Value Hedge Derivatives And Not Designated As Hedging Instruments At Fair Value
GainLossOnForeignCurrencyFairValueHedgeDerivativesAndNotDesignatedAsHedgingInstrumentsAtFairValue
292000 usd
CY2022Q4 epac Gain Loss On Foreign Currency Fair Value Hedge Derivatives And Not Designated As Hedging Instruments At Fair Value
GainLossOnForeignCurrencyFairValueHedgeDerivativesAndNotDesignatedAsHedgingInstrumentsAtFairValue
-636000 usd
CY2023Q4 us-gaap Increase Decrease In Fair Value Of Hedged Item In Interest Rate Fair Value Hedge1
IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
-100000 usd
CY2023Q4 us-gaap Translation Adjustment For Net Investment Hedge Increase Decrease Gross Of Tax
TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseGrossOfTax
100000 usd
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
29727622 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
826600000 usd
CY2023Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
10000000 shares
CY2023Q4 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
954907 shares
CY2023Q4 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
26100000 usd
CY2023Q4 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
3071608 shares
CY2023Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
18305000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
6409000 usd
CY2023Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
567000 usd
CY2022Q4 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-1044000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
17738000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
7453000 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54527000 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56886000 shares
CY2023Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
481000 shares
CY2022Q4 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
431000 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55008000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57317000 shares
CY2023Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.34
CY2022Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.11
CY2023Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.33
CY2022Q4 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.11
CY2023Q4 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTaxPerBasicShare
-0.01
CY2022Q4 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTaxPerBasicShare
0.02
CY2023Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.01
CY2022Q4 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.02
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.32
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
CY2023Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
312000 shares
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
818000 shares
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
326620000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
17738000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
370000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
51000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2023Q4 us-gaap Dividends Cash
DividendsCash
21000 usd
CY2023Q4 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
26116000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2717000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2210000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-2025000 usd
CY2023Q2 epac Stock Value Issuedto Acquired Forand Distributed From Rabbi Trust
StockValueIssuedtoAcquiredForandDistributedFromRabbiTrust
90000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
321676000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
318611000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
7453000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
6024000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
42000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2155000 usd
CY2023Q4 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
930000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-969000 usd
CY2022Q2 epac Stock Value Issuedto Acquired Forand Distributed From Rabbi Trust
StockValueIssuedtoAcquiredForandDistributedFromRabbiTrust
77000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
334323000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
23974000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8792000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5669000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2383000 usd
CY2023Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.236
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.271
CY2023Q4 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2023Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.236
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.271
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
141970000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
139382000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
28662000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
12309000 usd
CY2023Q4 us-gaap Assets
Assets
765567000 usd
CY2023Q3 us-gaap Assets
Assets
762597000 usd
CY2023Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
7000000 usd
CY2023Q3 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
8600000 usd
CY2023Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2023Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
2976000 usd
CY2022Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
3273000 usd
CY2023Q4 us-gaap Short Term Lease Cost
ShortTermLeaseCost
585000 usd
CY2022Q4 us-gaap Short Term Lease Cost
ShortTermLeaseCost
494000 usd
CY2023Q4 us-gaap Variable Lease Cost
VariableLeaseCost
919000 usd
CY2022Q4 us-gaap Variable Lease Cost
VariableLeaseCost
1115000 usd
CY2023Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
2956000 usd
CY2022Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
3255000 usd
CY2023Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
611000 usd
CY2022Q4 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
483000 usd
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000006955-23-000085-index-headers.html Edgar Link pending
0000006955-23-000085-index.html Edgar Link pending
0000006955-23-000085.txt Edgar Link pending
0000006955-23-000085-xbrl.zip Edgar Link pending
epac-011302023exhibit321.htm Edgar Link pending
epac-11302023exhibit311.htm Edgar Link pending
epac-11302023exhibit312.htm Edgar Link pending
epac-11302023exhibit322.htm Edgar Link pending
epac-20231130.htm Edgar Link pending
epac-20231130.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
epac-20231130_cal.xml Edgar Link unprocessable
epac-20231130_def.xml Edgar Link unprocessable
epac-20231130_lab.xml Edgar Link unprocessable
epac-20231130_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
epac-20231130_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending